PHARMACEUTICAL LAW PUBLICATION nº 77

Considerations on  the  pricing system for medicinal products. Lourdes Fraguas Gadea

Abuse of dominant position consisting on predatory prices. Spanish Competition Authority Astrazeneca inhalers Decision. Alfonso Gutiérrez Hernández and Alberto Pérez Hernández

Public supply of medicines. Doctrine generated by the Spanish Review Commissions on Public Procurement as of the entry into force of the Spanish Lay 9/2017 ( 2018-2021). 

Alberto Dorrego de Carlos and Marta Díaz García

Indirect taxation for the pharmaceutical sector. Brexit and COVID implications.

Aranxta de Luis Romero and Maria Teresa Deltell Ulecia

25º Pharmaceutical Lay Course Anniversary. Biomedicine. Public Health and medicinal products.
Fundación CEFI

 

Click here to access the publication

This post is also available in: Spanish

Otras noticias

Promotion of Research through IP protection

Three of the most recognized experts on IP farma in Spain Ángel García Vidal, profesor de Derecho Mercantil de la Universidad de Santiago de Compostela y Consejero Académico de Gómez Acebo y Pombo, Kiko Carrión García de Parada, Abogado socio

Leer Más >>

Clinical Research and data protection debate

Interesting debate with Jesús Rubí, Adjunto a la Dirección de la Agencia Española de Protección de Datos, Amelia Martín Uranga, Responsable de la Plataforma de Medicamentos Innovadores de Farmaindustria and Lluis Alcover, Abogado de Faus y Moliner. Interestingf debate about main

Leer Más >>